KAILERA THERAPEUTICS INC.

Lobbying client · Massachusetts · filed 2026 to 2026

Biotechnology company.

$20,000 Reported spend

2 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page comes from one LDA client record (74970), filed by the registrant listed below.

Who filed for this client 1

W STRATEGIES, LLC $20,000 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 1 year

2026 $20,000 2 filings

Issues lobbied 1

Pharmacy 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Recent filings 2 total

Q3 report

W STRATEGIES, LLC

3rd Quarter 2026 (July 1 - Sep 30) · $20,000 income · posted Oct 19, 2026

View → Registration

W STRATEGIES, LLC

3rd Quarter 2026 (July 1 - Sep 30) · posted Sep 16, 2026

View →

Keep going

Filings through October 19, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.